Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ric N Price

Showing results (161-170 of 318) with videos related to

Pageof 32
Sort By:
The Journal of Infectious Diseases|July 27, 2016
Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in ThailandSarah Auburn, David Serre, Richard D Pearson, et al.
Plos One|June 12, 2008
Safety profile of L-arginine infusion in moderately severe falciparum malariaTsin W Yeo, Daniel A Lampah, Retno Gitawati, et al.
Pathogens (Basel, Switzerland)|January 5, 2021
Diagnostic Practices and Treatment for <i>P. vivax</i> in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods StudyThuan Thi Nguyen, Xa Xuan Nguyen, Maya Ronse, et al.
The Journal of Infectious Diseases|September 22, 2018
Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent MalariaJessica R Loughland, Tonia Woodberry, Michelle J Boyle, et al.
Malaria Journal|December 12, 2018
Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillanceMatthew J Grigg, Timothy William, Kim A Piera, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal PhenotypesGrennady Wirjanata, Irene Handayuni, Pak Prayoga, et al.
Plos One|August 10, 2016
Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early LifeFaustina Helena Burdam, Mohammad Hakimi, Franciscus Thio, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2023
No Association between the Plasmodium vivax <i>crt-o</i> MS334 or In9<i>pvcrt</i> Polymorphisms and Chloroquine Failure in a Pre-Elimination Clinical Cohort from Malaysia with a Large Clonal ExpansionAngela Rumaseb, Roberto R Moraes Barros, Juliana M Sá, et al.
Plos One|May 13, 2017
Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infectionsZuleima Pava, Rintis Noviyanti, Irene Handayuni, et al.
The Journal of Infectious Diseases|June 15, 2013
Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivaxNicholas M Douglas, Julie A Simpson, Aung Pyae Phyo, et al.
Pageof 32

Showing results (161-170 of 318) with videos related to

Sort By:
Pageof 32
The Journal of Infectious Diseases|July 27, 2016
Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in ThailandSarah Auburn, David Serre, Richard D Pearson, et al.
Plos One|June 12, 2008
Safety profile of L-arginine infusion in moderately severe falciparum malariaTsin W Yeo, Daniel A Lampah, Retno Gitawati, et al.
Pathogens (Basel, Switzerland)|January 5, 2021
Diagnostic Practices and Treatment for <i>P. vivax</i> in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods StudyThuan Thi Nguyen, Xa Xuan Nguyen, Maya Ronse, et al.
The Journal of Infectious Diseases|September 22, 2018
Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent MalariaJessica R Loughland, Tonia Woodberry, Michelle J Boyle, et al.
Malaria Journal|December 12, 2018
Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillanceMatthew J Grigg, Timothy William, Kim A Piera, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal PhenotypesGrennady Wirjanata, Irene Handayuni, Pak Prayoga, et al.
Plos One|August 10, 2016
Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early LifeFaustina Helena Burdam, Mohammad Hakimi, Franciscus Thio, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2023
No Association between the Plasmodium vivax <i>crt-o</i> MS334 or In9<i>pvcrt</i> Polymorphisms and Chloroquine Failure in a Pre-Elimination Clinical Cohort from Malaysia with a Large Clonal ExpansionAngela Rumaseb, Roberto R Moraes Barros, Juliana M Sá, et al.
Plos One|May 13, 2017
Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infectionsZuleima Pava, Rintis Noviyanti, Irene Handayuni, et al.
The Journal of Infectious Diseases|June 15, 2013
Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivaxNicholas M Douglas, Julie A Simpson, Aung Pyae Phyo, et al.
Pageof 32